The global Complement Drug market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Complement Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Complement Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement Drug. This report contains market size and forecasts of Complement Drug in global, including the following market information:
Global Complement Drug market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Complement Drug companies in 2024 (%)
Total Market by Segment:
Global Complement Drug market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Complement Drug market segment percentages, by Type, 2024 (%)
Peptides
Antibodies
Others
Global Complement Drug market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Complement Drug market segment percentages, by Application, 2024 (%)
Blood Disease
Kidney Disease
Others
Global Complement Drug market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Complement Drug market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Complement Drug revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Complement Drug revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Alexion Pharmaceuticals
ChemoCentryx
Roche
Apellis
Regeneron
Amgen
Alnylam
UCB
InflaRx
ChemoCentryx
Innate Pharma
Ionis Pharmaceuticals
Avant Immunotherapeutics
Pfizer
Sanofi
Omeros
GenMab
Akari Therapeutics
AbbVie
Outline of Major Chapters:
Chapter 1: Introduces the definition of Complement Drug, market overview.
Chapter 2: Global Complement Drug market size in revenue.
Chapter 3: Detailed analysis of Complement Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Complement Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Complement Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Complement Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Complement Drug Overall Market Size
2.1 Global Complement Drug Market Size: 2024 VS 2032
2.2 Global Complement Drug Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Complement Drug Players in Global Market
3.2 Top Global Complement Drug Companies Ranked by Revenue
3.3 Global Complement Drug Revenue by Companies
3.4 Top 3 and Top 5 Complement Drug Companies in Global Market, by Revenue in 2024
3.5 Global Companies Complement Drug Product Type
3.6 Tier 1, Tier 2, and Tier 3 Complement Drug Players in Global Market
3.6.1 List of Global Tier 1 Complement Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Complement Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Complement Drug Market Size Markets, 2024 & 2032
4.1.2 Peptides
4.1.3 Antibodies
4.1.4 Others
4.2 Segmentation by Type - Global Complement Drug Revenue & Forecasts
4.2.1 Segmentation by Type - Global Complement Drug Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Complement Drug Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Complement Drug Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Complement Drug Market Size, 2024 & 2032
5.1.2 Blood Disease
5.1.3 Kidney Disease
5.1.4 Others
5.2 Segmentation by Application - Global Complement Drug Revenue & Forecasts
5.2.1 Segmentation by Application - Global Complement Drug Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Complement Drug Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Complement Drug Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Complement Drug Market Size, 2024 & 2032
6.2 By Region - Global Complement Drug Revenue & Forecasts
6.2.1 By Region - Global Complement Drug Revenue, 2020-2025
6.2.2 By Region - Global Complement Drug Revenue, 2026-2032
6.2.3 By Region - Global Complement Drug Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Complement Drug Revenue, 2020-2032
6.3.2 United States Complement Drug Market Size, 2020-2032
6.3.3 Canada Complement Drug Market Size, 2020-2032
6.3.4 Mexico Complement Drug Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Complement Drug Revenue, 2020-2032
6.4.2 Germany Complement Drug Market Size, 2020-2032
6.4.3 France Complement Drug Market Size, 2020-2032
6.4.4 U.K. Complement Drug Market Size, 2020-2032
6.4.5 Italy Complement Drug Market Size, 2020-2032
6.4.6 Russia Complement Drug Market Size, 2020-2032
6.4.7 Nordic Countries Complement Drug Market Size, 2020-2032
6.4.8 Benelux Complement Drug Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Complement Drug Revenue, 2020-2032
6.5.2 China Complement Drug Market Size, 2020-2032
6.5.3 Japan Complement Drug Market Size, 2020-2032
6.5.4 South Korea Complement Drug Market Size, 2020-2032
6.5.5 Southeast Asia Complement Drug Market Size, 2020-2032
6.5.6 India Complement Drug Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Complement Drug Revenue, 2020-2032
6.6.2 Brazil Complement Drug Market Size, 2020-2032
6.6.3 Argentina Complement Drug Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Complement Drug Revenue, 2020-2032
6.7.2 Turkey Complement Drug Market Size, 2020-2032
6.7.3 Israel Complement Drug Market Size, 2020-2032
6.7.4 Saudi Arabia Complement Drug Market Size, 2020-2032
6.7.5 UAE Complement Drug Market Size, 2020-2032
7 Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Complement Drug Major Product Offerings
7.1.4 Novartis AG Complement Drug Revenue in Global Market (2020-2025)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Alexion Pharmaceuticals
7.2.1 Alexion Pharmaceuticals Corporate Summary
7.2.2 Alexion Pharmaceuticals Business Overview
7.2.3 Alexion Pharmaceuticals Complement Drug Major Product Offerings
7.2.4 Alexion Pharmaceuticals Complement Drug Revenue in Global Market (2020-2025)
7.2.5 Alexion Pharmaceuticals Key News & Latest Developments
7.3 ChemoCentryx
7.3.1 ChemoCentryx Corporate Summary
7.3.2 ChemoCentryx Business Overview
7.3.3 ChemoCentryx Complement Drug Major Product Offerings
7.3.4 ChemoCentryx Complement Drug Revenue in Global Market (2020-2025)
7.3.5 ChemoCentryx Key News & Latest Developments
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Complement Drug Major Product Offerings
7.4.4 Roche Complement Drug Revenue in Global Market (2020-2025)
7.4.5 Roche Key News & Latest Developments
7.5 Apellis
7.5.1 Apellis Corporate Summary
7.5.2 Apellis Business Overview
7.5.3 Apellis Complement Drug Major Product Offerings
7.5.4 Apellis Complement Drug Revenue in Global Market (2020-2025)
7.5.5 Apellis Key News & Latest Developments
7.6 Regeneron
7.6.1 Regeneron Corporate Summary
7.6.2 Regeneron Business Overview
7.6.3 Regeneron Complement Drug Major Product Offerings
7.6.4 Regeneron Complement Drug Revenue in Global Market (2020-2025)
7.6.5 Regeneron Key News & Latest Developments
7.7 Amgen
7.7.1 Amgen Corporate Summary
7.7.2 Amgen Business Overview
7.7.3 Amgen Complement Drug Major Product Offerings
7.7.4 Amgen Complement Drug Revenue in Global Market (2020-2025)
7.7.5 Amgen Key News & Latest Developments
7.8 Alnylam
7.8.1 Alnylam Corporate Summary
7.8.2 Alnylam Business Overview
7.8.3 Alnylam Complement Drug Major Product Offerings
7.8.4 Alnylam Complement Drug Revenue in Global Market (2020-2025)
7.8.5 Alnylam Key News & Latest Developments
7.9 UCB
7.9.1 UCB Corporate Summary
7.9.2 UCB Business Overview
7.9.3 UCB Complement Drug Major Product Offerings
7.9.4 UCB Complement Drug Revenue in Global Market (2020-2025)
7.9.5 UCB Key News & Latest Developments
7.10 InflaRx
7.10.1 InflaRx Corporate Summary
7.10.2 InflaRx Business Overview
7.10.3 InflaRx Complement Drug Major Product Offerings
7.10.4 InflaRx Complement Drug Revenue in Global Market (2020-2025)
7.10.5 InflaRx Key News & Latest Developments
7.11 ChemoCentryx
7.11.1 ChemoCentryx Corporate Summary
7.11.2 ChemoCentryx Business Overview
7.11.3 ChemoCentryx Complement Drug Major Product Offerings
7.11.4 ChemoCentryx Complement Drug Revenue in Global Market (2020-2025)
7.11.5 ChemoCentryx Key News & Latest Developments
7.12 Innate Pharma
7.12.1 Innate Pharma Corporate Summary
7.12.2 Innate Pharma Business Overview
7.12.3 Innate Pharma Complement Drug Major Product Offerings
7.12.4 Innate Pharma Complement Drug Revenue in Global Market (2020-2025)
7.12.5 Innate Pharma Key News & Latest Developments
7.13 Ionis Pharmaceuticals
7.13.1 Ionis Pharmaceuticals Corporate Summary
7.13.2 Ionis Pharmaceuticals Business Overview
7.13.3 Ionis Pharmaceuticals Complement Drug Major Product Offerings
7.13.4 Ionis Pharmaceuticals Complement Drug Revenue in Global Market (2020-2025)
7.13.5 Ionis Pharmaceuticals Key News & Latest Developments
7.14 Avant Immunotherapeutics
7.14.1 Avant Immunotherapeutics Corporate Summary
7.14.2 Avant Immunotherapeutics Business Overview
7.14.3 Avant Immunotherapeutics Complement Drug Major Product Offerings
7.14.4 Avant Immunotherapeutics Complement Drug Revenue in Global Market (2020-2025)
7.14.5 Avant Immunotherapeutics Key News & Latest Developments
7.15 Pfizer
7.15.1 Pfizer Corporate Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Complement Drug Major Product Offerings
7.15.4 Pfizer Complement Drug Revenue in Global Market (2020-2025)
7.15.5 Pfizer Key News & Latest Developments
7.16 Sanofi
7.16.1 Sanofi Corporate Summary
7.16.2 Sanofi Business Overview
7.16.3 Sanofi Complement Drug Major Product Offerings
7.16.4 Sanofi Complement Drug Revenue in Global Market (2020-2025)
7.16.5 Sanofi Key News & Latest Developments
7.17 Omeros
7.17.1 Omeros Corporate Summary
7.17.2 Omeros Business Overview
7.17.3 Omeros Complement Drug Major Product Offerings
7.17.4 Omeros Complement Drug Revenue in Global Market (2020-2025)
7.17.5 Omeros Key News & Latest Developments
7.18 GenMab
7.18.1 GenMab Corporate Summary
7.18.2 GenMab Business Overview
7.18.3 GenMab Complement Drug Major Product Offerings
7.18.4 GenMab Complement Drug Revenue in Global Market (2020-2025)
7.18.5 GenMab Key News & Latest Developments
7.19 Akari Therapeutics
7.19.1 Akari Therapeutics Corporate Summary
7.19.2 Akari Therapeutics Business Overview
7.19.3 Akari Therapeutics Complement Drug Major Product Offerings
7.19.4 Akari Therapeutics Complement Drug Revenue in Global Market (2020-2025)
7.19.5 Akari Therapeutics Key News & Latest Developments
7.20 AbbVie
7.20.1 AbbVie Corporate Summary
7.20.2 AbbVie Business Overview
7.20.3 AbbVie Complement Drug Major Product Offerings
7.20.4 AbbVie Complement Drug Revenue in Global Market (2020-2025)
7.20.5 AbbVie Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Complement Drug Market Opportunities & Trends in Global Market
Table 2. Complement Drug Market Drivers in Global Market
Table 3. Complement Drug Market Restraints in Global Market
Table 4. Key Players of Complement Drug in Global Market
Table 5. Top Complement Drug Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Complement Drug Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Complement Drug Revenue Share by Companies, 2020-2025
Table 8. Global Companies Complement Drug Product Type
Table 9. List of Global Tier 1 Complement Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Complement Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Complement Drug Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Complement Drug Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Complement Drug Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Complement Drug Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Complement Drug Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Complement Drug Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Complement Drug Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Complement Drug Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Complement Drug Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Complement Drug Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Complement Drug Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Complement Drug Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Complement Drug Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Complement Drug Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Complement Drug Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Complement Drug Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Complement Drug Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Complement Drug Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Complement Drug Revenue, (US$, Mn), 2026-2032
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Complement Drug Product Offerings
Table 32. Novartis AG Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 33. Novartis AG Key News & Latest Developments
Table 34. Alexion Pharmaceuticals Corporate Summary
Table 35. Alexion Pharmaceuticals Complement Drug Product Offerings
Table 36. Alexion Pharmaceuticals Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 37. Alexion Pharmaceuticals Key News & Latest Developments
Table 38. ChemoCentryx Corporate Summary
Table 39. ChemoCentryx Complement Drug Product Offerings
Table 40. ChemoCentryx Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 41. ChemoCentryx Key News & Latest Developments
Table 42. Roche Corporate Summary
Table 43. Roche Complement Drug Product Offerings
Table 44. Roche Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 45. Roche Key News & Latest Developments
Table 46. Apellis Corporate Summary
Table 47. Apellis Complement Drug Product Offerings
Table 48. Apellis Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 49. Apellis Key News & Latest Developments
Table 50. Regeneron Corporate Summary
Table 51. Regeneron Complement Drug Product Offerings
Table 52. Regeneron Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 53. Regeneron Key News & Latest Developments
Table 54. Amgen Corporate Summary
Table 55. Amgen Complement Drug Product Offerings
Table 56. Amgen Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 57. Amgen Key News & Latest Developments
Table 58. Alnylam Corporate Summary
Table 59. Alnylam Complement Drug Product Offerings
Table 60. Alnylam Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 61. Alnylam Key News & Latest Developments
Table 62. UCB Corporate Summary
Table 63. UCB Complement Drug Product Offerings
Table 64. UCB Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 65. UCB Key News & Latest Developments
Table 66. InflaRx Corporate Summary
Table 67. InflaRx Complement Drug Product Offerings
Table 68. InflaRx Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 69. InflaRx Key News & Latest Developments
Table 70. ChemoCentryx Corporate Summary
Table 71. ChemoCentryx Complement Drug Product Offerings
Table 72. ChemoCentryx Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 73. ChemoCentryx Key News & Latest Developments
Table 74. Innate Pharma Corporate Summary
Table 75. Innate Pharma Complement Drug Product Offerings
Table 76. Innate Pharma Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 77. Innate Pharma Key News & Latest Developments
Table 78. Ionis Pharmaceuticals Corporate Summary
Table 79. Ionis Pharmaceuticals Complement Drug Product Offerings
Table 80. Ionis Pharmaceuticals Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 81. Ionis Pharmaceuticals Key News & Latest Developments
Table 82. Avant Immunotherapeutics Corporate Summary
Table 83. Avant Immunotherapeutics Complement Drug Product Offerings
Table 84. Avant Immunotherapeutics Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 85. Avant Immunotherapeutics Key News & Latest Developments
Table 86. Pfizer Corporate Summary
Table 87. Pfizer Complement Drug Product Offerings
Table 88. Pfizer Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 89. Pfizer Key News & Latest Developments
Table 90. Sanofi Corporate Summary
Table 91. Sanofi Complement Drug Product Offerings
Table 92. Sanofi Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 93. Sanofi Key News & Latest Developments
Table 94. Omeros Corporate Summary
Table 95. Omeros Complement Drug Product Offerings
Table 96. Omeros Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 97. Omeros Key News & Latest Developments
Table 98. GenMab Corporate Summary
Table 99. GenMab Complement Drug Product Offerings
Table 100. GenMab Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 101. GenMab Key News & Latest Developments
Table 102. Akari Therapeutics Corporate Summary
Table 103. Akari Therapeutics Complement Drug Product Offerings
Table 104. Akari Therapeutics Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 105. Akari Therapeutics Key News & Latest Developments
Table 106. AbbVie Corporate Summary
Table 107. AbbVie Complement Drug Product Offerings
Table 108. AbbVie Complement Drug Revenue (US$, Mn) & (2020-2025)
Table 109. AbbVie Key News & Latest Developments
List of Figures
Figure 1. Complement Drug Product Picture
Figure 2. Complement Drug Segment by Type in 2024
Figure 3. Complement Drug Segment by Application in 2024
Figure 4. Global Complement Drug Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Complement Drug Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Complement Drug Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Complement Drug Revenue in 2024
Figure 9. Segmentation by Type � Global Complement Drug Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Complement Drug Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Complement Drug Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Complement Drug Revenue Market Share, 2020-2032
Figure 13. By Region - Global Complement Drug Revenue Market Share, 2020-2032
Figure 14. By Country - North America Complement Drug Revenue Market Share, 2020-2032
Figure 15. United States Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Complement Drug Revenue Market Share, 2020-2032
Figure 19. Germany Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 20. France Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Complement Drug Revenue Market Share, 2020-2032
Figure 27. China Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 31. India Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Complement Drug Revenue Market Share, 2020-2032
Figure 33. Brazil Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Complement Drug Revenue Market Share, 2020-2032
Figure 36. Turkey Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Complement Drug Revenue, (US$, Mn), 2020-2032
Figure 40. Novartis AG Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Alexion Pharmaceuticals Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. ChemoCentryx Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Roche Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Apellis Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Regeneron Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Amgen Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Alnylam Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. UCB Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. InflaRx Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. ChemoCentryx Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Innate Pharma Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Ionis Pharmaceuticals Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Avant Immunotherapeutics Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Pfizer Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Sanofi Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 56. Omeros Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 57. GenMab Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 58. Akari Therapeutics Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 59. AbbVie Complement Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
